What products liability insurance do medical device manufacturers need?

For a medical device manufacturer, products liability is not an add-on - it is the primary exposure. The vast majority of device claims arise from the finished product in the field (malfunction, design or manufacturing defect, inadequate warnings), not from operations inside the facility. So the program is built around the products-and-completed-operations line, with limits driven by two things: the device's FDA risk class and what the manufacturer's contracts require.

Revenue is a weak proxy for the right limit here. A small-revenue maker of a Class III implantable can carry far higher limits than a larger maker of a Class I instrument, because the bodily-injury severity is what drives both carrier appetite and contract demands.

Class I (low risk - bandages, basic instruments, most general-hospital devices): often general-exempt from premarket review. Products liability commonly sits at $1M/$2M to $2M/$4M, sometimes as part of a package policy. The exposure is real but severity is typically lower.

Class II (moderate risk - most devices, cleared via 510(k): infusion pumps, surgical instruments, many diagnostics): products liability typically runs $2M-$5M, higher when the device is patient-contacting or used in a critical-care setting. GPO and hospital contracts at this tier frequently specify $2M-$5M with the completed-operations endorsement.

Class III (high risk - PMA pathway: implantables, life-sustaining and life-supporting devices): products liability commonly starts at $5M-$10M and scales into the tens of millions via an umbrella/excess tower. Carrier appetite narrows, underwriting is device-specific, and clinical and adverse-event history matters to pricing and availability.

Most device revenue flows through GPO supplier agreements and direct hospital purchase contracts, and those contracts dictate the insurance schedule. The recurring requirements: products and completed operations liability at a stated limit (commonly $2M-$10M depending on device class), the hospital or GPO named as additional insured for products/completed operations (not just ongoing operations), primary and non-contributory wording, waiver of subrogation, and 30-day notice of cancellation.

Credentialing platforms (Symplr, Reptrax/IntelliCentrics, Vendormate) validate the certificate of insurance line by line before a sales rep can enter a facility. A products tower that meets the dollar limit but lacks the completed-operations additional-insured endorsement will be rejected at credentialing - which is the most common place a device maker discovers a gap.

The single most important - and most commonly missed - piece is the additional-insured-for-products-and-completed-operations endorsement. Most general liability policies provide blanket additional-insured for ongoing operations by default, but exclude products/completed operations from that blanket. For a device manufacturer, ongoing-operations additional-insured provides almost no protection, because the claims that get filed arise from the finished device after it has shipped.

The fix is ISO CG 20 37 (per-contract) or, for makers serving many hospitals and GPOs, a manuscripted blanket completed-operations endorsement that automatically extends the status to any party the manufacturer has agreed in writing to cover. Dedicated medical-device markets write the manuscripted blanket routinely; generic commercial markets often do not, which is how a device maker insured in a generic program ends up non-compliant at contract review.

A device program rarely stops at products liability. Common companions: an umbrella/excess tower to reach the $5M-$10M+ limits Class II/III contracts require; product recall coverage for the first-party cost of a field action or FDA recall (the products policy covers third-party injury, not the recall logistics); professional/E&O or a combined products-completed-operations-and-professional form for devices where a design or instructional defect blurs the product/service line; and clinical trial liability while a device is still in human studies.

For software-driven and connected devices, cyber liability and SaMD (software as a medical device) considerations also enter the program. The right structure is exposure-specific - a sterile implantable maker and a connected-monitoring SaMD company need materially different towers even at the same revenue.

Products liability premium for a medical device manufacturer varies widely by class and claims history. A Class I/II maker in the low-single-digit-millions revenue range commonly runs $10,000-$60,000 annually for the products line; Class II patient-contacting devices push higher; Class III/implantable programs frequently run six figures and are underwritten device-by-device. The umbrella tower, recall coverage, and any professional/clinical-trial lines are priced on top.